Healthcare provider profile · identity verified

Paul A Spinner, MD

Family Practice · BECKER, MN · NPI 1538141908

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	327	89
Atorvastatin Calcium	Atorvastatin Calcium	313	91
Rosuvastatin Calcium	Rosuvastatin Calcium	293	85
Omeprazole	Omeprazole	283	77
Amlodipine Besylate	Amlodipine Besylate	258	73
Lisinopril	Lisinopril	238	63
Metoprolol Succinate	Metoprolol Succinate	175	49
Trazodone Hcl	Trazodone Hcl	160	37
Simvastatin	Simvastatin	155	46
Hydrochlorothiazide	Hydrochlorothiazide	143	42
Levothyroxine Sodium	Levothyroxine Sodium	130	32
Pantoprazole Sodium	Pantoprazole Sodium	126	29
Eliquis	Apixaban	124	22
Duloxetine Hcl	Duloxetine Hcl	123	30
Furosemide	Furosemide	108	32
Tamsulosin Hcl	Tamsulosin Hcl	104	35
Metoprolol Tartrate	Metoprolol Tartrate	93	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	89	17
Gabapentin	Gabapentin	88	22
Metformin Hcl	Metformin Hcl	88	24
Tramadol Hcl	Tramadol Hcl	87	16
Jardiance	Empagliflozin	84	16
Mirtazapine	Mirtazapine	80	17
Allopurinol	Allopurinol	79	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	23
Lorazepam	Lorazepam	74	17
Buspirone Hcl	Buspirone Hcl	73	15
Amitriptyline Hcl	Amitriptyline Hcl	64	17
Zolpidem Tartrate	Zolpidem Tartrate	64	suppressed
Warfarin Sodium	Warfarin Sodium	63	17
Fluticasone Propionate	Fluticasone Propionate	61	18
Carvedilol	Carvedilol	59	14
Metformin Hcl Er	Metformin Hcl	58	18
Escitalopram Oxalate	Escitalopram Oxalate	56	16
Alendronate Sodium	Alendronate Sodium	55	18
Potassium Chloride	Potassium Chloride	55	15
Ezetimibe	Ezetimibe	52	15
Fluoxetine Hcl	Fluoxetine Hcl	51	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	16
Alprazolam	Alprazolam	50	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	11
Pravastatin Sodium	Pravastatin Sodium	47	11
Tizanidine Hcl	Tizanidine Hcl	45	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	15
Meloxicam	Meloxicam	43	11
Montelukast Sodium	Montelukast Sodium	43	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	39	15
Sertraline Hcl	Sertraline Hcl	39	12
Donepezil Hcl	Donepezil Hcl	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Finasteride	Finasteride	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	23
Spironolactone	Spironolactone	34	suppressed
Atenolol	Atenolol	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Famotidine	Famotidine	31	11
Glimepiride	Glimepiride	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Celecoxib	Celecoxib	26	13
Hydrocortisone	Hydrocortisone	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	suppressed
Amoxicillin	Amoxicillin	25	14
Ozempic	Semaglutide	25	suppressed
Glipizide	Glipizide	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Azithromycin	Azithromycin	15	12
Colchicine	Colchicine	15	suppressed
Prednisone	Prednisone	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Torsemide	Torsemide	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Nortrel	Norethindrone-Ethin. Estradiol	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Glyxambi	Empagliflozin/Linagliptin	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error